SBI Leasing Services Co.,Ltd. Logo

SBI Leasing Services Co.,Ltd.

Structures Japanese Operating Leases for aircraft & ships for corporate investors.

5834 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区六本木一丁目6番1号 泉ガーデンタワー14階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SBI Leasing Services Co., Ltd., established in 2017, is a financial services firm specializing in structuring and providing Japanese Operating Lease (JOL) products for investments in real assets. The company purchases high-value assets, primarily commercial aircraft and ships, and leases them to global airlines and shipping companies. It creates investment funds based on these leases for corporate investors. Key products include the standard JOL and the JOLCO (Japanese Operating Lease with Call Option), which offer investors benefits such as distributed lease income, potential capital gains, and significant tax advantages like profit equalization and deferral.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 08:36
Regulatory News Service
訂正発行登録書
Japanese 8.8 KB
2025-06-30 08:24
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB
2025-06-24 03:34
Regulatory News Service
内部統制報告書-第8期(2024/04/01-2025/03/31)
Japanese 26.3 KB
2025-06-24 03:32
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-24 03:30
Annual Report
有価証券報告書-第8期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2025-02-20 02:30
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 54.8 KB
2024-12-02 07:30
Prospectus
発行登録書(株券、社債券等)
Japanese 28.6 KB
2024-11-13 07:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-13 07:30
Interim Report
半期報告書-第8期(2024/04/01-2025/03/31)
Japanese 180.2 KB
2024-10-04 08:40
Share Issue/Capital Change
訂正臨時報告書
Japanese 29.4 KB
2024-08-30 08:55
Share Issue/Capital Change
臨時報告書
Japanese 28.1 KB
2024-08-30 08:53
Share Issue/Capital Change
臨時報告書
Japanese 30.0 KB
2024-06-27 09:25
Post-Annual General Meeting Information
臨時報告書
Japanese 26.1 KB
2024-06-25 09:06
Regulatory News Service
内部統制報告書-第7期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-25 09:05
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all SBI Leasing Services Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SBI Leasing Services Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea 007390
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan 2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan 4893

Talk to a Data Expert

Have a question? We'll get back to you promptly.